BR0114046A - Peptìdeos reguladores e auxiliares de hiv, antìgenos, composições de vacinas, kit de imunoensaio e um método para detectar anticorpos induzidos por hiv - Google Patents
Peptìdeos reguladores e auxiliares de hiv, antìgenos, composições de vacinas, kit de imunoensaio e um método para detectar anticorpos induzidos por hivInfo
- Publication number
- BR0114046A BR0114046A BR0114046-9A BR0114046A BR0114046A BR 0114046 A BR0114046 A BR 0114046A BR 0114046 A BR0114046 A BR 0114046A BR 0114046 A BR0114046 A BR 0114046A
- Authority
- BR
- Brazil
- Prior art keywords
- hiv
- antigens
- peptides
- vaccine compositions
- induced antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/974—Aids related test
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses
Abstract
"PEPTìDEOS REGULADORES E AUXILIARES DE HIV, ANTìGENOS, COMPOSIçõES DE VACINAS, KIT DE IMUNOENSAIO E UM MéTODO PARA DETECTAR ANTICORPOS INDUZIDOS POR HIV". A presente invenção compreende peptídeos inovadores e modificados capazes de induzir uma resposta imunológica específica de HIV-1, sem antagonizar a atividade citotóxica de células T, para conseguir uma vacina profilática e terapêutica eficaz contra HIV. Os peptídeos baseiam-se em regiões conservadas das proteínas reguladoras Tat e Rev, e da proteína auxiliar Nef, de HIV. Descrevem-se também antígenos na forma livre ou ligados a veículos, compreendendo pelo menos um dos ditos peptídeos, composições de vacinas contendo pelo menos um dos antígenos, kits de imunoensaio e um método para detectar anticorpos induzidos por HIV ou peptídeos específicos de HIV, usando tais antígenos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20004412A NO314587B1 (no) | 2000-09-04 | 2000-09-04 | HIV regulatoriske- og hjelpepeptider, antigener, vaksinepreparater, immunoassay testsett og en metode for påvisning av antistoffer fremkaltav HIV |
| PCT/NO2001/000363 WO2002020555A2 (en) | 2000-09-04 | 2001-09-03 | Hiv peptides from tat, rev and wef conserved regions and their application as e.g.vaccine components |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0114046A true BR0114046A (pt) | 2003-07-22 |
Family
ID=19911532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0114046-9A BR0114046A (pt) | 2000-09-04 | 2001-09-03 | Peptìdeos reguladores e auxiliares de hiv, antìgenos, composições de vacinas, kit de imunoensaio e um método para detectar anticorpos induzidos por hiv |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7097971B2 (pt) |
| EP (1) | EP1322666B1 (pt) |
| JP (1) | JP2004508382A (pt) |
| CN (2) | CN101628933A (pt) |
| AR (1) | AR033997A1 (pt) |
| AT (1) | ATE378350T1 (pt) |
| AU (2) | AU8633601A (pt) |
| BR (1) | BR0114046A (pt) |
| CA (1) | CA2421199A1 (pt) |
| DE (1) | DE60131432T2 (pt) |
| EA (1) | EA006210B1 (pt) |
| ES (1) | ES2296793T3 (pt) |
| HU (1) | HUP0303132A3 (pt) |
| NO (1) | NO314587B1 (pt) |
| NZ (2) | NZ535908A (pt) |
| SK (1) | SK287913B6 (pt) |
| WO (1) | WO2002020555A2 (pt) |
| ZA (1) | ZA200301742B (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6982086B2 (en) | 2000-02-04 | 2006-01-03 | Duke University | Human immunodeficiency virus immunogenic composition |
| CA2645342A1 (en) | 2006-03-10 | 2007-09-20 | Peptcell Limited | Peptides of regulatory or accessory proteins of hiv, compositions and the utilization thereof |
| JP4931483B2 (ja) * | 2006-06-14 | 2012-05-16 | ルネサスエレクトロニクス株式会社 | 半導体不良解析装置、不良解析方法、及び不良解析プログラム |
| EP3187585A1 (en) | 2010-03-25 | 2017-07-05 | Oregon Health&Science University | Cmv glycoproteins and recombinant vectors |
| CN102210874A (zh) * | 2011-05-17 | 2011-10-12 | 浙江大学 | 一种hiv重组亚型dna疫苗的制备方法 |
| PL2691530T3 (pl) | 2011-06-10 | 2019-02-28 | Oregon Health & Science University | Glikoproteiny i rekombinowane wektory CMV |
| US20130189754A1 (en) | 2011-09-12 | 2013-07-25 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
| US9402894B2 (en) | 2011-10-27 | 2016-08-02 | International Aids Vaccine Initiative | Viral particles derived from an enveloped virus |
| MX2014014683A (es) * | 2012-06-06 | 2015-02-24 | Bionor Immuno As | Peptidos derivados de proteinas virales para usarse como inmunogenos y reactivos de dosificacion. |
| ES2631608T3 (es) | 2012-06-27 | 2017-09-01 | International Aids Vaccine Initiative | Variante de la glicoproteína Env del VIH-1 |
| DK2928910T3 (da) * | 2012-12-06 | 2019-10-07 | Pin Pharma Inc | Behandling af inflammation, autoimmune og neurodegenerative sygdomme med immunosuppressive tat-derivat polypeptider |
| US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
| EP2873423B1 (en) | 2013-10-07 | 2017-05-31 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
| EP3069730A3 (en) | 2015-03-20 | 2017-03-15 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
| EP3072901A1 (en) | 2015-03-23 | 2016-09-28 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5219990A (en) * | 1991-01-28 | 1993-06-15 | Biogen, Inc. | Papillomavirus e2 trans-activation repressors |
| WO1994015634A1 (en) * | 1992-12-30 | 1994-07-21 | Matthias Rath | Tat and rev oligopeptides in hiv treatment |
| WO1996027389A1 (fr) * | 1995-03-08 | 1996-09-12 | Neovacs | Immunogenes denues de toxicite derivant d'une proteine de regulation retrovirale, anticorps, procede de preparation et compositions pharmaceutiques les renfermant |
| US5891994A (en) * | 1997-07-11 | 1999-04-06 | Thymon L.L.C. | Methods and compositions for impairing multiplication of HIV-1 |
| IT1297090B1 (it) | 1997-12-01 | 1999-08-03 | Barbara Ensoli | Tat di hiv-1 o suoi derivati, da soli od in combinazione, a scopo vaccinale, profilattico e terapeutico, contro l'aids i tumori e le |
| FR2773156B1 (fr) | 1997-12-26 | 2000-03-31 | Biovacs Inc | Nouveaux immunogenes anti-retroviraux (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida |
| NO311807B1 (no) | 1999-03-04 | 2002-01-28 | Bionor Immuno As | HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV |
| WO2000078969A1 (en) | 1999-06-21 | 2000-12-28 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Hiv tat peptides and multiple peptide conjugate system |
| SE0001351L (sv) * | 2000-04-12 | 2001-03-26 | Kjell Sjoegren | Smådjurstoalett |
-
2000
- 2000-09-04 NO NO20004412A patent/NO314587B1/no not_active IP Right Cessation
-
2001
- 2001-09-03 EA EA200300335A patent/EA006210B1/ru not_active IP Right Cessation
- 2001-09-03 CN CN200910140941A patent/CN101628933A/zh active Pending
- 2001-09-03 JP JP2002525175A patent/JP2004508382A/ja active Pending
- 2001-09-03 NZ NZ535908A patent/NZ535908A/xx not_active IP Right Cessation
- 2001-09-03 WO PCT/NO2001/000363 patent/WO2002020555A2/en active IP Right Grant
- 2001-09-03 US US10/129,333 patent/US7097971B2/en not_active Expired - Fee Related
- 2001-09-03 AT AT01965768T patent/ATE378350T1/de not_active IP Right Cessation
- 2001-09-03 CA CA002421199A patent/CA2421199A1/en not_active Abandoned
- 2001-09-03 EP EP01965768A patent/EP1322666B1/en not_active Expired - Lifetime
- 2001-09-03 AU AU8633601A patent/AU8633601A/xx active Pending
- 2001-09-03 DE DE60131432T patent/DE60131432T2/de not_active Expired - Lifetime
- 2001-09-03 BR BR0114046-9A patent/BR0114046A/pt not_active IP Right Cessation
- 2001-09-03 SK SK401-2003A patent/SK287913B6/sk not_active IP Right Cessation
- 2001-09-03 ES ES01965768T patent/ES2296793T3/es not_active Expired - Lifetime
- 2001-09-03 NZ NZ524557A patent/NZ524557A/en not_active IP Right Cessation
- 2001-09-03 AU AU2001286336A patent/AU2001286336B2/en not_active Ceased
- 2001-09-03 HU HU0303132A patent/HUP0303132A3/hu unknown
- 2001-09-03 CN CN01815739A patent/CN1458936A/zh active Pending
- 2001-09-04 AR ARP010104195A patent/AR033997A1/es active IP Right Grant
-
2003
- 2003-03-03 ZA ZA200301742A patent/ZA200301742B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1322666B1 (en) | 2007-11-14 |
| NO20004412L (no) | 2002-03-05 |
| JP2004508382A (ja) | 2004-03-18 |
| EP1322666A2 (en) | 2003-07-02 |
| AU2001286336B2 (en) | 2007-03-15 |
| NO20004412D0 (no) | 2000-09-04 |
| NZ524557A (en) | 2005-04-29 |
| EA200300335A1 (ru) | 2003-08-28 |
| HUP0303132A3 (en) | 2012-09-28 |
| NO314587B1 (no) | 2003-04-14 |
| CN101628933A (zh) | 2010-01-20 |
| US7097971B2 (en) | 2006-08-29 |
| DE60131432D1 (de) | 2007-12-27 |
| CA2421199A1 (en) | 2002-03-14 |
| WO2002020555A2 (en) | 2002-03-14 |
| ZA200301742B (en) | 2004-06-21 |
| US20050053616A1 (en) | 2005-03-10 |
| AR033997A1 (es) | 2004-01-21 |
| ATE378350T1 (de) | 2007-11-15 |
| NZ535908A (en) | 2006-03-31 |
| EA006210B1 (ru) | 2005-10-27 |
| AU8633601A (en) | 2002-03-22 |
| SK287913B6 (sk) | 2012-03-02 |
| ES2296793T3 (es) | 2008-05-01 |
| DE60131432T2 (de) | 2008-09-18 |
| WO2002020555A3 (en) | 2002-06-06 |
| HUP0303132A2 (hu) | 2005-03-29 |
| CN1458936A (zh) | 2003-11-26 |
| SK4012003A3 (en) | 2003-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0114036A (pt) | Peptìdeos de hiv, antìgenos, composições de vacina, kit de imunoensaio e um método para detectar anticorpos induzidos pelo hiv | |
| BR0008741A (pt) | Peptìdeo de hiv, antìgenos, composições de vacina, kit de imunoensaio e método de detecção de anticorpos induzidos por hiv | |
| BR0114046A (pt) | Peptìdeos reguladores e auxiliares de hiv, antìgenos, composições de vacinas, kit de imunoensaio e um método para detectar anticorpos induzidos por hiv | |
| BR0210598A (pt) | Complexo solúvel que compreende uma glicoproteìna retroviral de superfìcie | |
| ATE380822T1 (de) | Funf-helix protein | |
| DE69737736D1 (de) | Induktion rev- und tat-spezifischer zytotoxischer t-zellen zur prävention und behandlung einer infektion durch humanen immundefizienz-virus (hiv) | |
| DE68927348T2 (de) | Künstlicher impfstoff gegen aids-virus | |
| ES2013346A6 (es) | Metodos para producir secuencias y moleculas de adn recombinante, asi como proteinas t4 solubles. | |
| ES2010727A6 (es) | Metodo para producir lineas celulares que producen anticuerpos monoclonales reactivos frente a determinantes antigenicos de gp110 o de p25 de hiv. | |
| EP1016671A3 (en) | Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) | |
| Nygren et al. | 95-and 25-kDa fragments of the human immunodeficiency virus envelope glycoprotein gp120 bind to the CD4 receptor. | |
| ATE435034T1 (de) | Expression und charakterisierung eines hiv-1 hüllproteins, das mit einer breitreaktiven neutralisierenden antikörperantwort assoziiert ist. | |
| Bernsen et al. | Herpes simplex virus specific antibody determined by immunoblotting in cerebrospinal fluid of a patient with the Guillain-Barré syndrome. | |
| FR2874017B1 (fr) | Peptides vih-1 modifies et leur utilisation en detection d'anticorps anti-vih | |
| FR2646607B1 (fr) | Anticorps monoclonaux anti-b2 microglobuline | |
| EP0808846A3 (en) | Peptides which react with antiboby representing the prognostic marker for HIV disease progression | |
| RU2000106709A (ru) | Пептиды-имитаторы консервативного эпитопа белка gp41 вируса иммунодефицита человека типа 1, узнаваемого вируснейтрализующими моноклональными антителами 2f5 | |
| TH65071A (th) | เพพไทด์ควบคุม และอนุเคราะห์ hiv แอนติเจน องค์ประกอบวัคซีนชุดสำเร็จรูปอิมมูโนแอสเสย์และวิธีการของการตรวจหาแอนติบอดีที่ถูกชักนำโดย hiv | |
| TH62264A (th) | Hiv เพพไทด์, แอนติเจน องค์ประกอบวัคซีน, ชุดสำเร็จรูปอิมมูโนแอสเสย์ และวิธีสำหรับตรวจหาแอนติบอดีที่ชักนำโดย hiv |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 12A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014. |